Master Service Agreement CHDR & INFECTA

July 4, 2025

Yes, we did it! Cheers to our partnership! πŸ₯‚

Last Friday, we signed the Master Service Agreement between Centre for Human Drug Research (CHDR) and INFECTA.

This is a huge milestone for INFECTA, symbolizing not only the start of our collaboration but also the trust we are building for the future.

Through this partnership, INFECTA will be able to conduct Phase 1 clinical trials in the highly professional, optimized environment of CHDR while we continue building the Infection Unit.

A big thank you to Geert Jan Groeneveld and Anouk de Jong for your trust, vision, and friendship in this process. We are excited for what lies ahead!

 

Let’s accelerate the development of your infectious disease product together